Assistant Professor, Surgery, Perelman School of Medicine
General Surgery
Dr. Robert E. Roses, MD
|
|
Give Review
Robert E. Roses, MD is an expert in the field of General Surgery. He attended Tufts University School of Medicine. Tufts University School of Medicine is ranked 49 in research and 52 in primary care medicine He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Robert E. Roses is also a published physician. He has 49 publication published. The most recent publication is: Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis. He is registered with Medicare.
Publications
- Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched Analysis.
- Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
- The efficacy of adjuvant therapy for pancreatic invasive intraDuctal papillary mucinous neoplasm (IPMN).
- Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short-term oncologic outcomes.
- Neoadjuvant therapy for gastric Cancer: current evidence and future directions.
- Drain Management after Pancreatoduodenectomy: Reappraisal of a Prospective Randomized Trial Using Risk Stratification.
- Adjuvant Radiation Therapy Treatment Time Impacts Overall Survival in Gastric Cancer.
- Clinicopathologic characteristics of incidentally identified pheochromocytoma.
- Long-term blood pressure control in patients undergoing Adrenalectomy for primary hyperaldosteronism.
- Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy.
- Outcomes after resection of leiomyosarcomas of the inferior vena cava: A pooled data Analysis of 377 cases.
- PTCH 1 Staining of Pancreatic Neuroendocrine Tumor (PNET) samples from patients with and without Multiple Endocrine Neoplasia (MEN-1) Syndrome Reveals a Potential Ther...
- The rise in metastasectomy across Cancer types over the past decade.
- Resection of primary leiomyoSarcoma of the inferior vena cava (IVC) with reconstruction: A case series and review of the literature.
- Radiation as Immunomodulator: Implications for Dendritic Cell-Based Immunotherapy.
- Implications of inadequate lymph node staging in resectable gastric Cancer: A contemporary analysis using the National Cancer Data Base.
- Hernia repair in the presence of ascites.
- Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database.
- Surgical Palliation for Pancreatic Malignancy: Practice Patterns and Predictors of Morbidity and Mortality.
- The palliative index: predicting outcomes of emergent surgery in patients with Cancer.
- Preoperative radiation for retroperitoneal Sarcoma is not associated with increased early postoperative morbidity.
- Clark Level Risk Stratifies Patients with Mitogenic Thin Melanomas for Sentinel Lymph Node Biopsy.
- Morbidity and Mortality of CytoreDuction with Intraperitoneal Chemotherapy: Outcomes from the ACS NSQIP Database.
- The effect of colorectal Cancer screening mandates on access to care and clinical outcomes: A retrospective study of patients undergoing operations of the colon and re...
- Response to HER-2 Pulsed DC1 Vaccines is Predicted by Both HER-2 and Estrogen Receptor Expression in DCIS.
- Sartorius transposition during inguinal lymphadenectomy for melanoma.
- Surgery for metastatic Neuroendocrine tumors with occult primaries.
- Biology, treatment, and outcome in very young and older women with DCIS.
- Multidisciplinary management of hepatocellular carcinoma.
- HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact Ductal carcinoma in situ.
- Transplantation or resection for hepatocellular carcinoma: biology determines outcome.
- The significance of HER-2/neu receptor positivity and immunophenotype in Ductal carcinoma in situ with early invasive disease.
- Axillary Failure in Patients Treated with MammoSite Accelerated Partial Breast Irradiation.
- Ductal Carcinoma-In-Situ of the Breast with Subsequent Distant Metastasis and Death.
- Revisiting the rotating call schedule in less than 80 hours per week.
- Asymptomatic changes in cardiac function can occur in Ductal carcinoma-in-situ patients following treatment with HER-2/neu-pulsed dendritic cell vaccines.
- HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast Cancer.
- Differential proDuction of IL-23 and IL-12 by myeloid-derived dendritic cells in response to TLR agonists.
- Development of vaccines for high-risk Ductal carcinoma in situ of the breast.
- Tissue engineered cartilage integration to live and devitalized cartilage: a study by reflectance mode confocal microscopy and standard histology.
- Producing a flexible Tissue-engineered cartilage framework using expanded polytetrafluoroethylene membrane as a pseudoperichondrium.
- Injectable Tissue-engineered cartilage with different chondrocyte sources.
- Cancer in the gastric remnant after gastric bypass: a case report.
- The state of general surgery training: a different perspective.
- Radiation therapy and Toll-like receptor signaling: implications for the treatment of Cancer.
- Interpretation of intra-operative PTH changes in patients with multi-Glandular primary hyperparathyroidism (pHPT).
- Reengineering dendritic cell-based anti-Cancer vaccines.
- Recent trends in the surgical management of inflammatory bowel Disease.
Schools
Tufts University
Procedures Preformed
- Adrenalectomy
- Appendectomy, Laparoscopic
- Appendectomy, Open
- Colectomy
- View All
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Appendicitis
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
University of Pennsylvania Health System -
Tufts University School of Medicine
Hospital
-
Hospital of the University of Pennsylvania
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760539423 |
| Last Name Of The Provider | ROSES |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Mark-Mina M. Ishak, DO |
|
|
Dr. Katarzyna M. Wolanin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leandra Krowsoski, MD |
|
|
Dr. Adam P. Johnson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine E. Feldmeier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edmund K. Bartlett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Narong Keosathit, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael T. Friel, MD |
|
|
Dr. David W. Low, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|